Cardlytics, Inc.

Cardlytics reported Q2 2026 revenue of $36.88 million, a significant decrease from $58.04 million in the prior year, and a net loss of $(14.88) million, widening from $(9.28) million YoY. The company completed a 1-for-10 reverse stock split on June 5, 2026, and finalized the divestiture of its Bridg platform in March 2026, which contributed a $13.9 million gain from discontinued operations for the six-month period. Cash and cash equivalents stood at $28.04 million, with net cash used in operating activities increasing to $(14.24) million for the first six months of 2026.

Cardlytics, Inc. received a notice from Nasdaq regarding its common stock trading below the $1.00 minimum bid price for 30 consecutive business days, potentially leading to delisting. The company has 180 calendar days, until November 30, 2026, to regain compliance. In response, Cardlytics filed a Charter Amendment to effect a 1-for-10 reverse stock split and reduce authorized shares from 100 million to 10 million, effective June 5, 2026. Split-adjusted trading will commence on June 8, 2026, reducing outstanding shares from approximately 58.1 million to 5.8 million.

Cardlytics announced that Nick Lynton, its Chief Legal and Privacy Officer, will resign from his position, effective by July 3, 2026, or earlier if a successor is appointed. He will continue to provide services through the effective date, potentially in a non-officer advisory role for transition. In connection with his departure, Lynton will receive a $380,000 lump sum separation payment, up to 12 months of COBRA premium reimbursement, and an additional $70,320.21 payment in the first quarter of 2027, subject to compliance with the transition and release agreements.

Cardlytics, Inc. completed the divestment of its Bridg platform on March 24, 2026, receiving 1,810,222 shares of PAR Technology Corporation common stock and recording a $14.5 million gain on divestiture. For the first quarter of 2026, the company reported a total net loss of $4.48 million, a significant improvement from the $13.28 million net loss in Q1 2025, largely due to the gain from discontinued operations. Revenue from continuing operations decreased to $34.32 million from $56.44 million year-over-year.

Cardlytics reported Q1 2026 financial results, with revenue from continuing operations of $34.3 million, a 39% decrease year-over-year. The company achieved a net loss of $(4.5) million, an improvement from $(13.3) million in Q1 2025, and Adjusted EBITDA turned positive at $0.2 million. These results reflect the successful divestiture of Bridg on March 24, 2026, which contributed $9.3 million in income from discontinued operations. Cardlytics also provided Q2 2026 guidance, anticipating Billings between $61.0 million and $67.0 million.